# Expanded Access Study of Fenretinide Lym-X-Sorb Plus Ketoconazole in Neuroblastoma

> **NCT02075177** · — · NO_LONGER_AVAILABLE · sponsor: **South Plains Oncology Consortium**

## Conditions studied

- Recurrent Neuroblastoma
- Neuroblastoma

## Interventions

- **DRUG:** Fenretinide Lym-X-Sorb Oral Powder
- **DRUG:** Ketoconazole

## Key facts

- **NCT ID:** NCT02075177
- **Lead sponsor:** South Plains Oncology Consortium
- **Sponsor class:** NETWORK
- **Phase:** —
- **Study type:** EXPANDED_ACCESS
- **Status:** NO_LONGER_AVAILABLE
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2022-03-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02075177

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02075177, "Expanded Access Study of Fenretinide Lym-X-Sorb Plus Ketoconazole in Neuroblastoma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02075177. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*